Galecto

-$0.13 (-9.63%) Today
+$0.03 (+2.46%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galecto and other ETFs, options, and stocks.

About GLTO

Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211.

CEO
Hans Thalsgård Schambye
Employees
40
Headquarters
Boston, Massachusetts
Founded
2011

GLTO Key Statistics

Market cap
31.73M
Price-Earnings ratio
—
Dividend yield
—
Average volume
77.88K
High today
$1.33
Low today
$1.17
Open price
$1.33
Volume
47.70K
52 Week high
$16.41
52 Week low
$1.17

GLTO Earnings

-$55.25
-$36.83
-$18.42
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure